Search Results 831-840 of 16179 for chemoprevention
A Mayo Clinic medical oncologist answers questions about diagnosis and screening and discusses treatment advances in recent years for gastric and esophageal ...
The Mayo Mammography Health Study group has published numerous articles on mammographic density, genetic variations in breast cancer risk and survivor ...
The purposes of this study are to determine the levels of prostate cancer-derived extracellular vesicles pre- and post-local therapy (radical prostatectomy ...
The Tumor Development, Immunology & Progression Lab of Peter Storz, Ph.D., at Mayo Clinic studies cell signaling events, pancreatic cancer development ...
The purpose of this study is to determine if the complete clinical response rate of patients with Stage I-IIIB (cT1-3, N0-1, M0) rectal cancer being treated ...
This new analysis compared use of lapatinib or trastuzumab alone, as well as outcome in disease-free patients who were offered trastuzumab as adjuvant treatment ...
The no show rate for mammography screening is high among Navajo women. One barrier to preventive screening is a lack of cancer literacy including low ...
New technology allows Mayo Clinic radiation oncologists to carefully plan and deliver radiation so that cancer cells are killed and healthy tissue nearby is ...
The Epigenetic Etiology of Human Disease Laboratory at Mayo Clinic is studying epigenetic mutations at the epigenome and transcriptome levels.
The purpose of this study is to evaluate the effectiveness and tolerability of cryotherapy (cold therapy) in the form of Elasto Gel® frozen mittens and foot ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.